Hologic Inc: Fortifying Market Position Through Innovation & Strategic Acquisitions!

Hologic reported its fiscal Q1 2024 results, demonstrating strong financial performance with total revenue reaching $1.01 billion, above the high end of the company’s guidance. In spite of four fewer selling days than in Q1 2023, the firm achieved total organic revenue growth, excluding COVID-19, of 5.2%. When adjusted for the fewer selling days, estimated total company organic revenue growth excluding COVID-19 was in the high single digits. Both operating expenses and tax rate were as expected while a $500 million shares repurchase was initiated during the quarter.